Prosecution Insights
Last updated: September 06, 2026

Examiner: FOWLER, DANIEL WAYNE

Tech Center 3700 • Art Units: 3739 3794

This examiner grants 73% of resolved cases

Performance Statistics

72.7%
Allow Rate
+2.7% vs TC avg
964
Total Applications
+12.2%
Interview Lift
1221
Avg Prosecution Days
Based on 930 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
14.5%
§102 Novelty
49.6%
§103 Obviousness
27.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19540301 SYSTEM AND METHOD FOR DETERMINING STATE OF RF DEVICES USING IMPEDANCE MEASUREMENTS Final Rejection Boston Scientific Scimed, Inc.
18917294 SIMULTANEOUS ELECTROSURGICAL SEALING AND CUTTING Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
18686272 Flexible Telescopic Shaft for Monopolar Electrosurgical Pencil Final Rejection Stryker European Operations Limited
18916553 DEVICES AND METHODS FOR SHALLOW DEPTH ABLATION Non-Final OA Covidien LP
18565011 ELECTROSURGICAL FORCEPS WITH TISSUE CONTACT SENSING Non-Final OA Covidien LP
18023799 THERMAL CUTTING ELEMENTS, ELECTROSURGICAL INSTRUMENTS INCLUDING THERMAL CUTTING ELEMENTS, AND METHODS OF MANUFACTURING Non-Final OA Covidien LP
18758612 DOUBLE-SIDED ENCAPSULATED PLANAR CATHETER WITH ENCAPSULATING POLYMER Final Rejection Biosense Webster (Israel) Ltd.
18760413 USER INTERFACE AND LOCK FEATURES FOR POSITIONING MULTIPLE COMPONENTS WITHIN A BODY Final Rejection GYRUS ACMI, INC., D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18609204 ELECTROSURGICAL INSTRUMENT Final Rejection GYRUS ACMI, INC., D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18868003 DEVICE AND METHOD FOR TREATMENT OF PART OF A HUMAN BODY Non-Final OA BTL Medical Solutions a.s.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month